循環器ジャーナル68巻3号

2020年07月発行

特集 不整脈治療の最新デバイステクノロジーとリードマネジメント Ⅲ．植込みデバイス手術の合併症

合併症の種類

著者： 楊培慧¹ 髙木雅彦²

所属機関： ¹関西医科大学総合医療センター循環器腎内分泌代謝内科 ²関西医科大学総合医療センター不整脈治療センター

ページ範囲：P.466 - P.474

Point
・植込み型心臓電気デバイスに伴う合併症は，ポケット関連とリード関連の合併症があり，周術期のみならず遠隔期にも発生する．合併症の内容とその予防策，トラブルシューティングを十分に知っておく必要がある．
・経静脈リードシステムの合併症を予防する目的で，ヒス束ペーシング，リードレスペースメーカ，皮下植込み型除細動器などが施行されるようになってきたが，それらに対しても新たな合併症が報告されている．
・植込み型除細動器や心臓再同期治療では，デバイスの大きさ，リードの硬さ・太さ，手技の難しさなどから，ペースメーカより合併症の発生率が高くなる．

参考文献

1) Cantillon DJ, Exner DV, Badie N, et al:Complications and Health Care Costs Associated With Transvenous Cardiac Pacemakers in a Nationwide Assessment. JACC Clin Electrophysiol 3:1296-1305, 2017

2) Udo EO, Zuithoff NP, van Hemel NM, et al:Incidence and predictors of sfort-and long-term complications in pacemaker therapy:The FOLLOWPACE study. Heart Rhythm 9:728-735, 2012

3) Yasaka M, Naritomi H, Minematsu K:Ischemic stroke associated with brief cessation of warfarin. Thromb Res 118:290-293, 2006

4) Birnie DH, Healey JS, Wells GA, et al:Pacemaker or defibrillator surgery without interruption of anticoagulation. N Engl J Med 368:2084-2093, 2013

5) Birnie DH, Healey JS, Wells GA, et al:Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events（BRUISE CONTROL-2）. Eur Heart J 39:3973-3979, 2018

6) Essebag V, Healey JS, Joza J, et al:Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma:Combined Analysis of BRUISE CONTROL 1 and 2. Circ Arrhythm Electrophysiol 12:e007545, 2019

7) Nakajima H, Taki M;Incidence of cardiac implantable electronic device infections and migrations in Japan:Results from a 129 institute survey. J Arrhythm 32:303-307, 2016

8) de Oliveira JC, Martinelli M, Nishioka SA, et al:Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators:results of large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythm Electrophysiol 2:29-34, 2009

9) Baddour LM, Epstein AE, Erickson CC, et al:Update on cardiovascular implantable electronic device infections and their management:a scientific statement from the American Heart Association. Circulation 121:458-477, 2010

10) 日本循環器学会：不整脈非薬物治療ガイドライン（2018年改訂版）．2019　http://www.j-circ.or.jp/guideline/pdf/JCS2018_kurita_nogami.pdf

11) Vijayaraman P, Dandamudi G:How to Perform Permanent His Bundle Pacing:tips and Tricks. Pacing Clin Electrophysiol. 39:1298-1304, 2016

12) Lustgarten DL, Sharma PS, Vijayaraman P:Troubleshooting and programming considerations for His bundle pacing. Heart rhythm 16:654-662, 2019

13) Abdelrahman M, Subzposh FA, Beer D, et al:Clinical Outcomes of His Bundle Pacing Compared to Right Ventricular Pacing. J Am Coll Cardiol 71:2319-2330, 2018

14) Zanon F, Ellenbogen KA, Dandamudi G, et al:Permanent His-bundle pacing:a systematic literature review and meta-analysis. Europace 20:1819-1826, 2018

15) Zanon F, Svetlich C, Occhetta E, et al:Safety and Performance of a System Specifically Designed for Selective Site Pacing. Pacing Clin Electrophysiol. 34:339-347, 2011

16) Vijayaraman P, Naperkowski A, Subzposh FA, et al:Permanent His-bundle pacing:Long-term lead performance and clinical outcomes. Heart Rhythm 15:696-702, 2018

17) Lee JZ, Mulpuru SK, Shen WK:Leadless pacemaker:performance and complications. Trends Cardiovasc Med 28:130-141, 2018

18) El-Chami MF, Al-Samadi F, Clementy N, et al:Updated performance of the Micra transcatheter pacemaker in the real-world setting:A cmparison to the investigational study and a transvenous historical control. Heart Rhythm 15:1800-1807, 2018

19) Cantillon DJ, Dukkipati SR, Ip JH, et al:Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemaakers. Heart rhythm 15:1023-1030, 2018

20) Palmisano P, Accogli M, Zaccaria M, et al:Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision:large population survey from two centres in Italy. Europace 15:531-540, 2013

21) Oswald H, Asbach S, Köbe J, et al:Effectiveness and Reliability of Selected Site Pacing for Avoidance of Phrenic Nerve Stimulation in CRT Patients with Quadripolar LV Leads:The EffaceQ Study. Pacing Clin Electrophysiol 38:942-950, 2015

22) Juliá J, López-Gil M, Fontenla A, et al:Super-response to cardiac resynchronization therapy may predict late phrenic nerve stimulation. Europace 20:1498-1505, 2018

23) Burke MC, Gold MR, Knight BP, et al:Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator:2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. J Am Coll Cardiol 65:1605-1615, 2015

24) Gold MR, Aasbo JD, El-Chami MF, et al:Subcutaneous implantable cardioverter-defibrillator Post-Approval Study:Clinical characteristics and perioperative results. Heart Rhythm 14:1456-1463, 2017

25) Brouwer TF, Driessen AHG, Olde Nordkamp LRA, et al:Surgical Management of Implantation-Related Complications of the Subcutaneous Implantable Cardioverter-Defibrillator. JACC Clin Electrophysiol 2:89-96, 2016